High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Simple summaryWe investigated the role of Ki67, a ubiquitous marker in cancer, within the context of ductal carcinoma in situ (DCIS), a precursor of invasive breast cancer. Through rigorous analysis of histopathological and immunopathological samples from a substantial cohort, this study revealed ro...
Saved in:
Main Authors: | Hossein Schandiz, Lorant Farkas, Daehoon Park, Yan Liu, Solveig N. Andersen, Torill Sauer, Jürgen Geisler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1467664/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-institutional evaluation comparing guidance from International Ki67 Working Group vs National Health Commission of China on immunohistochemistry-based Ki67 assessment alongside the Quantitative Dot Blot method
by: Yin Wang, et al.
Published: (2025-01-01) -
The value of multiparametric MRI radiomics and machine learning in predicting preoperative Ki-67 expression level in breast cancer
by: Yan Lu, et al.
Published: (2025-01-01) -
Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA
by: Tianzhao Du, et al.
Published: (2024-12-01) -
Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
by: Wang Wenhui, et al.
Published: (2024-12-01) -
The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)